Wealthcare Advisory Partners’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,700
| Closed | -$202K | – | 894 |
|
|
2024
Q2 | $202K | Buy |
+1,700
| New | +$202K | 0.01% | 787 |
|
|
2023
Q4 | – | Sell |
-2,642
| Closed | -$273K | – | 761 |
|
|
2023
Q3 | $273K | Sell |
2,642
-568
| -18% | -$58.7K | 0.01% | 575 |
|
|
2023
Q2 | $390K | Sell |
3,210
-1,037
| -24% | -$126K | 0.02% | 502 |
|
|
2023
Q1 | $652K | Sell |
4,247
-1,792
| -30% | -$275K | 0.03% | 385 |
|
|
2022
Q4 | $1.08M | Sell |
6,039
-198
| -3% | -$35.6K | 0.05% | 264 |
|
|
2022
Q3 | $738K | Sell |
6,237
-503
| -7% | -$59.5K | 0.04% | 281 |
|
|
2022
Q2 | $963K | Sell |
6,740
-109
| -2% | -$15.6K | 0.06% | 212 |
|
|
2022
Q1 | $1.18M | Sell |
6,849
-1,336
| -16% | -$230K | 0.07% | 165 |
|
|
2021
Q4 | $2.08M | Sell |
8,185
-640
| -7% | -$163K | 0.12% | 102 |
|
|
2021
Q3 | $3.4M | Buy |
8,825
+113
| +1% | +$43.5K | 0.22% | 67 |
|
|
2021
Q2 | $2.05M | Buy |
8,712
+1,977
| +29% | +$465K | 0.14% | 104 |
|
|
2021
Q1 | $882K | Buy |
6,735
+4,070
| +153% | +$533K | 0.06% | 198 |
|
|
2020
Q4 | $278K | Buy |
+2,665
| New | +$278K | 0.02% | 334 |
|
|
2020
Q2 | – | Sell |
-175
| Closed | -$5K | – | 970 |
|
|
2020
Q1 | $5K | Buy |
+175
| New | +$5K | ﹤0.01% | 1111 |
|